HRP20130161T1 - Granulat koji sadrži nikotin - Google Patents

Granulat koji sadrži nikotin Download PDF

Info

Publication number
HRP20130161T1
HRP20130161T1 HRP20130161AT HRP20130161T HRP20130161T1 HR P20130161 T1 HRP20130161 T1 HR P20130161T1 HR P20130161A T HRP20130161A T HR P20130161AT HR P20130161 T HRP20130161 T HR P20130161T HR P20130161 T1 HRP20130161 T1 HR P20130161T1
Authority
HR
Croatia
Prior art keywords
nicotine
granules containing
containing nicotine
accordance
complex
Prior art date
Application number
HRP20130161AT
Other languages
English (en)
Inventor
Tillmann RÖHRICH
Original Assignee
Siegfried Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Siegfried Ltd. filed Critical Siegfried Ltd.
Publication of HRP20130161T1 publication Critical patent/HRP20130161T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1635Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34Tobacco-abuse

Claims (12)

1. Postupak dobivanja granulata koji sadrži nikotin, naznačen time što se sastoji u koracima (a) miješanja nikotina ili farmaceutski prihvatljive nikotinske soli ili kompleksa s pomoćnom tvari; (b) sabijanje smjese dobivene u koraku (a) u kompaktoru s valjcima kako bi se dobile granule; i (c) prosijavanja granula dobivenih u koraku (b) kako bi se uklonile čestice manje od 150 µm.
2. Postupak dobivanja granulata koji sadrži nikotin u skladu s patentnim zahtjevom 1, naznačen time što dodatno uključuje korak (d) recikliranja malih čestica uklonjenih u koraku (c) i njihovog dodavanja u smjesu iz koraka (a).
3. Postupak dobivanja granulata koji sadrži nikotin u skladu s patentnim zahtjevom 1 ili 2, naznačen time što se granulat koji sadrži nikotin proizvodi kontinuirano.
4. Postupak dobivanja granulata koji sadrži nikotin koji ima veličinu čestica od najmanje 150 µm u skladu s bilo kojim od patentnih zahtjeva 1 do 3, naznačen time što se homogena smjesa 1-50%, težinski, nikotina ili farmaceutski prihvatljive nikotinske soli ili kompleksa i 50-99%, težinski, pomoćne tvari pripravlja u koraku (a).
5. Postupak dobivanja granulata koji sadrži nikotin u skladu s patentnim zahtjevom 4, naznačen time što se homogena smjesa 10-30%, težinski, nikotina ili farmaceutski prihvatljive nikotinske soli ili kompleksa i 70-90%, težinski, pomoćne tvari pripravlja u koraku (a).
6. Postupak dobivanja granulata koji sadrži nikotin u skladu s patentnim zahtjevom 4 ili 5, naznačen time što je farmaceutski prihvatljiva nikotinska sol ili kompleks upotrijebljeni u koraku (a) čvrsta nikotinska sol ili kompleks, a osobito čvrsta nikotinska sol ili kompleks koje se bira iz skupine koju čine nikotin-bitartarat, nikotin-polakrilin, nikotin-betadeks, nikotin-polakrileks, te njihove kombinacije.
7. Postupak dobivanja granulata koji sadrži nikotin u skladu s bilo kojim od patentnih zahtjeva 4 do 6, naznačen time što se pomoćnu tvar upotrijebljenu u koraku (a) bira iz skupine koju čine monosaharidi, disaharidi, hidratirani ili nehidratirani oligosaharidi, monosaharidni alkoholi, disaharidni alkoholi, škrob, škrobni derivati, celuloza, inulin, šećerni alkoholi, kalcijev karbonat, kalcijev hidrogenfosfat, maltodekstrini, polisaharidi, te njihove kombinacije.
8. Postupak dobivanja granulata koji sadrži nikotin u skladu s patentnim zahtjevom 7, naznačen time što se pomoćnu tvar upotrijebljenu u koraku (a) bira iz skupine koju čine saharoza, laktoza, glukoza, fruktoza, ksiloza, škrob, sorbitol, manitol, ksilitol, šećerni alkoholi, celuloza, kalcijev karbonat, kalcijev hidrogenfosfat, maltodekstrin, te njihove kombinacije.
9. Postupak dobivanja granulata koji sadrži nikotin u skladu s bilo kojim od patentnih zahtjeva 4 do 8, naznačen time što se sladila, veziva, sredstva za razdvajanje, maziva, bojila, arome, kiseline, pjenila, antioksidante, sredstva za kliženje i/ili konzervanse pomiješa s drugim komponentama u koraku (a).
10. Upotreba granulata koji sadrži nikotin, dobivenog postupkom u skladu s patentnim zahtjevom 1, naznačena time što je granulat namijenjen pripravi farmaceutskog proizvoda koji sadrži nikotin.
11. Upotreba granulata koji sadrži nikotin, dobivenog postupkom u skladu s patentnim zahtjevom 1, naznačena time što je granulat namijenjen pripravi farmaceutskog proizvoda koji sadrži nikotin, namijenjenog za oralnu primjenu.
12. Upotreba granulata koji sadrži nikotin, dobivenog postupkom u skladu s patentnim zahtjevom 1, naznačena time što je granulat namijenjen pripravi farmaceutskog proizvoda koji sadrži nikotin, namijenjenog za transdermalnu primjenu.
HRP20130161AT 2008-09-17 2013-02-25 Granulat koji sadrži nikotin HRP20130161T1 (hr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08016336A EP2177213B1 (en) 2008-09-17 2008-09-17 Nicotine-containing granulate

Publications (1)

Publication Number Publication Date
HRP20130161T1 true HRP20130161T1 (hr) 2013-03-31

Family

ID=40091848

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20130161AT HRP20130161T1 (hr) 2008-09-17 2013-02-25 Granulat koji sadrži nikotin

Country Status (17)

Country Link
US (1) US10413512B2 (hr)
EP (1) EP2177213B1 (hr)
AR (1) AR073604A1 (hr)
AU (1) AU2009294964B2 (hr)
CA (1) CA2734402C (hr)
DK (1) DK2177213T3 (hr)
ES (1) ES2401912T3 (hr)
HR (1) HRP20130161T1 (hr)
MX (1) MX2011002696A (hr)
NZ (1) NZ591198A (hr)
PA (1) PA8842701A1 (hr)
PL (1) PL2177213T3 (hr)
PT (1) PT2177213E (hr)
SI (1) SI2177213T1 (hr)
UY (1) UY32127A (hr)
WO (1) WO2010031536A1 (hr)
ZA (1) ZA201101123B (hr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE533487T1 (de) * 2008-12-19 2011-12-15 Siegfried Ltd Nikotinhaltiges produkt
US9629805B2 (en) 2013-03-07 2017-04-25 Amneal Pharmaceuticals Llc Stabilization of moisture-sensitive drugs
EP3052081B1 (en) * 2013-10-03 2020-12-09 Altria Client Services LLC Lozenge
US10105320B2 (en) 2013-10-03 2018-10-23 Altria Client Services Soluble fiber lozenge
US11779045B2 (en) 2013-10-03 2023-10-10 Altria Client Services Llc Dissolvable-chewable exhausted-tobacco tablet
US9999243B2 (en) 2013-10-03 2018-06-19 Altria Client Services Llc Exhausted tobacco lozenge
US9351936B2 (en) 2013-10-03 2016-05-31 Altria Client Services Llc Nicotine lozenge
US10244786B2 (en) 2013-10-03 2019-04-02 Altria Client Services Llc Tobacco lozenge
CN108024966A (zh) * 2015-09-14 2018-05-11 默克专利股份有限公司 具有受控延迟活性成分释放的制剂
EP3445344B1 (en) 2016-04-21 2020-08-19 Fertin Pharma A/S Nicotine delivery product, related uses and oral dosage forms, and methods of production
WO2018233795A1 (en) * 2017-06-23 2018-12-27 Fertin Pharma A/S NICOTINE POCKET
AU2018378648B2 (en) 2017-12-08 2021-06-03 Fertin Pharma A/S Nicotine tablet
CA3085063A1 (en) * 2017-12-08 2019-06-13 Fertin Pharma A/S Solid oral nicotine formulation
EP3993646B1 (en) * 2019-07-05 2023-08-16 Swedish Match North Europe AB An oral pouched nicotine product including a filling material comprising nicotine-containing particles
ES2967603T3 (es) 2019-11-20 2024-05-03 Swedish Match North Europe Ab Un producto de nicotina en bolsa oral que incluye un material de relleno que comprende partículas de nicotina
US11969502B2 (en) 2019-12-09 2024-04-30 Nicoventures Trading Limited Oral products
US11793230B2 (en) 2019-12-09 2023-10-24 Nicoventures Trading Limited Oral products with improved binding of active ingredients
US11826462B2 (en) 2019-12-09 2023-11-28 Nicoventures Trading Limited Oral product with sustained flavor release
US11672862B2 (en) * 2019-12-09 2023-06-13 Nicoventures Trading Limited Oral products with reduced irritation
US11872231B2 (en) 2019-12-09 2024-01-16 Nicoventures Trading Limited Moist oral product comprising an active ingredient
US20220313678A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Spray dried nicotine for inclusion in oral products
US20220313614A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Encapsulated nicotine granules and methods of preparation thereof
US20220354785A1 (en) * 2021-04-22 2022-11-10 Nicoventures Trading Limited Oral lozenge products
CN114304712A (zh) * 2021-12-17 2022-04-12 深圳市元雾科技有限公司 一种液体高负载的尼古丁口含制品颗粒及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104787B (fi) 1989-06-07 2000-04-14 Xyrofin Oy Fruktoosipohjainen rakeistettu tuote ja menetelmä sen valmistamiseksi
SE8904295D0 (sv) * 1989-12-21 1989-12-21 Pharmacia Ab Smoking substitute
US5135753A (en) * 1991-03-12 1992-08-04 Pharmetrix Corporation Method and therapeutic system for smoking cessation
US6276917B1 (en) * 1999-01-28 2001-08-21 Botanicals International Powder processing apparatus
FR2792200B3 (fr) * 1999-04-16 2001-06-08 Unicliffe Ltd Substitut du tabac sous forme d'un comprime ou d'une pastille a sucer
DE19943496C1 (de) 1999-09-10 2001-05-17 Suedzucker Ag Direkt verpressbarer Rohstoff für Komprimate
WO2002076605A1 (de) 2001-03-23 2002-10-03 Symrise Gmbh & Co. Kg Verfahren zur herstellung von einkapselungen
WO2004056363A2 (en) 2002-12-20 2004-07-08 Niconovum Ab A physically and chemically stable nicotine-containing particulate material
US20070269492A1 (en) * 2006-05-16 2007-11-22 Per Steen New product and use and manufacture thereof
WO2008012071A2 (en) 2006-07-24 2008-01-31 Antares Pharma Ipl Ag Pharmaceutical compositions of nicotine and methods of use thereof

Also Published As

Publication number Publication date
EP2177213B1 (en) 2013-01-02
US20110165253A1 (en) 2011-07-07
AU2009294964B2 (en) 2012-12-13
PT2177213E (pt) 2013-02-21
PA8842701A1 (es) 2010-04-21
ZA201101123B (en) 2012-04-25
CA2734402C (en) 2013-05-14
PL2177213T3 (pl) 2013-08-30
DK2177213T3 (da) 2013-02-11
MX2011002696A (es) 2011-04-05
SI2177213T1 (sl) 2013-03-29
WO2010031536A1 (en) 2010-03-25
US10413512B2 (en) 2019-09-17
CA2734402A1 (en) 2010-03-25
AR073604A1 (es) 2010-11-17
NZ591198A (en) 2012-03-30
AU2009294964A1 (en) 2010-03-25
EP2177213A1 (en) 2010-04-21
UY32127A (es) 2010-04-30
ES2401912T3 (es) 2013-04-25

Similar Documents

Publication Publication Date Title
HRP20130161T1 (hr) Granulat koji sadrži nikotin
CN1099846C (zh) 颗粒状的餐桌调味强化食品的制备方法及其产品
CN103491949B (zh) 片剂型的口服给药用组合物及其制造方法
DE69434640T2 (de) Heterodisperse Hydrogelsysteme zur verzögerten Freisetzung unlöslicher Arzneistoffe
Khan et al. Enhancement of dissolution rate of class II drugs (Hydrochlorothiazide); a comparative study of the two novel approaches; solid dispersion and liqui-solid techniques
Gowthamarajan et al. Preliminary study of Anacardium occidentale gum as binder in formulation of paracetamol tablets
CN105555258A (zh) 包含无定形达格列净的制剂
CA2058959C (en) A fructose-based granulated product and a process for the production th ereof
WO2006108592A1 (de) Instantprodukt
CN101756917A (zh) 盐酸多奈哌齐口腔崩解片及其制备方法
WO2001003674A1 (de) Verfahren zur herstellung schnell zerfallender, fester pharmazeutischer zubereitungen
KR20150039643A (ko) 갈조류로부터 플로로탄닌 정제물의 제조방법
CN106018618B (zh) 草酸艾司西酞普兰片剂组合物和质控方法
KR20140001207A (ko) 압축성 고점도 다당류 및 폴리올 분말
CN100475195C (zh) 牛黄上清微丸及其制备方法
CN103417501B (zh) 托吡酯药物组合物
CN104523631A (zh) 一种治疗抑郁症的奥氮平口腔崩解片的制备方法
US6190687B1 (en) Method for preparing an extract of active principles in the form of microgranules based on dietary fibers
JP2007039441A (ja) 打錠用糖アルコール粉末組成物
CN1311822C (zh) 水飞蓟的缓释制剂
CN100546655C (zh) 含有中药提取物的片剂组合物及其制造方法
CN103006714A (zh) 一种红色诺卡氏菌细胞壁骨架缓释制剂及其制备方法
JP3796848B2 (ja) 生薬類配合固形組成物
Burra et al. Enhancement of solubility and dissolution rate of Frusemide through liquisolid technique
CN100502840C (zh) 一种治疗慢性鼻炎、鼻窦炎的药物